Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $161,740 - $207,493
-1,037 Reduced 14.5%
6,113 $1.05 Million
Q1 2022

May 09, 2022

SELL
$181.39 - $234.03 $315,799 - $407,446
-1,741 Reduced 19.58%
7,150 $1.35 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $405,780 - $517,527
2,095 Added 30.83%
8,891 $2.17 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $193,075 - $213,883
1,020 Added 17.66%
6,796 $1.32 Million
Q2 2021

Aug 10, 2021

BUY
$155.9 - $187.99 $900,478 - $1.09 Million
5,776 New
5,776 $1.08 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Dcm Advisors, LLC Portfolio

Follow Dcm Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcm Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcm Advisors, LLC with notifications on news.